In vitro and in vivo evidence for direct dopaminergic inhibition of VIP-immunoreactive pituitary cells
- 31 July 1994
- journal article
- Published by Elsevier in Neuropeptides
- Vol. 27 (1) , 1-6
- https://doi.org/10.1016/0143-4179(94)90009-4
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Hypothyroidism increases vasoactive intestinal polypeptide (VIP) immunoreactivity and gene expression in the rat hypothalamic paraventricular nucleusEndocrinology, 1992
- The Effect of Gonadal Steroids on Vasoactive Intestinal Peptide Concentration and Release from Mediobasal Hypothalamus and the Anterior Pituitary GlandJournal of Neuroendocrinology, 1991
- Vasoactive Intestinal Peptide in the Hypothalamus and PituitaryNeuroendocrinology, 1991
- THYROID HORMONE REGULATES VASOACTIVE INTESTINAL PEPTIDE (VIP) mRNA LEVELS IN THE RAT ANTERIOR PITUITARY GLANDEndocrinology, 1989
- Vasoactive Intestinal Peptide in the Anterior Pituitary Is Increased in Hypothyroidism*Endocrinology, 1989
- Vasoactive Intestinal Polypeptide Is Synthesized in Anterior Pituitary Tissue*Endocrinology, 1986
- Antisera to Vasoactive Intestinal Polypeptide Inhibit Basal Prolactin Release from Dispersed Anterior Pituitary CellsNeuroendocrinology, 1986
- Immunoreactive Vasoactive Intestinal Polypeptide in Rat Hypophysial Portal BloodEndocrinology, 1981
- Vasoactive intestinal peptide (VIP): Brain distribution, subcellular localization and effect of deafferentation of the hypothalamus in male ratsBrain Research, 1979
- Vasoactive intestinal polypeptide: Release into hypophyseal portal bloodLife Sciences, 1979